The cost- effectiveness of introducing nucleic acid testing to test for hepatitis B, hep- atitis C, and human immunodeficiency virus among blood donors in Swe- den. Transfusion. 2011 Feb;51(2):421-9.Davidson T,Ekermo B,Gaines H,et al.The cost-effectiveness of in-troducing nucleic acid ...
Our Hepatitis B test screens for HBV in the blood. Hep B can damage the liver if left untreated. The difference between acute & chronic hepatitis explained.
Combined effect of bias and annealing in gamma and neutron radiation assurance tests of SiGe bipolar transistors for HEP applications SiGe BiCMOS technologies are one of the proposed options for the front-end readout electronics of the detectors in the middle region of the ATLAS-Upgrade. ... M ...
Semantic Scholar ResearchGate onAcademic inspirehep.net epj-conferences.org 查看更多 相似文献 参考文献ENEA-Bologna production and testing of JEFF-3.1 multi-group cross section libraries for nuclear fission applications The ENEA-Bologna Nuclear Data Group produced the JEFF-3.1 VITJEFF31.BOLIB and MATJEF...
The following search strategy was developed incorporating search terms used in similar reviews and in consultation with a university librarian: (“hepatitis B” OR (hep AND b) OR “hep* B” OR “viral hepatitis”) AND (interventions OR process* OR strateg* OR procedure OR screen* OR “mass...
由人體免疫系統製成來抵抗乙肝病毒。 有抗體即有保護,可以免受乙肝感染。 乙型肝炎表面抗原(HBsAg) 如在血液中發現,即表明感染了乙肝。 如在人體內停留時間超過 6 個月,即表明患有慢性乙肝。 可在6 個月內重複檢查,以得出準確的診斷。 結果 乙肝檢查結果意味著什麼?
Hepatitis B is first diagnosed using a blood test that looks for certain antigens (fragments of HBV) and antibodies (produced by the immune system in response to HBV). The test is called a hepatitis B blood panel, and it checks for the following: ...
Trends in testing behaviours for hepatitis C virus infection and associated determinants: Results from population-based laboratory surveillance in Alberta, Canada (1998-2001). J Viral Hep 2007;14:249-54.Jayaraman GC, Lee B, Singh AE, Preiksaitis JK. Trends in testing behaviours for hepatitis C ...
Jenny Domyeum2, Gwenaëlle Maradan4, Jacques Ducos7, Eitel Mpoudi-Ngolé2, Bruno Spire4, Eric Delaporte1, Christopher Kuaban8, Laurent Vidal4, Christian Laurent1* , for the EVOLCAM study group Abstract Background: Hepatitis B is a major concern in Africa, especially in HIV-infected patien...
Less cost-effective is point-of-care HCVAb testing in fingerstick blood followed by NAT in venipuncture blood. Least cost-effective is the strategy requiring the tested person to return for NAT. 展开 DOI: 10.1002/hep.27966 被引量: 9 ...